Argentina Iron Deficiency Anemia Therapy Market Size & Outlook
Related Markets
Argentina iron deficiency anemia therapy market highlights
- The Argentina iron deficiency anemia therapy market generated a revenue of USD 19.2 million in 2022 and is expected to reach USD 40.4 million by 2030.
- The Argentina market is expected to grow at a CAGR of 9.8% from 2023 to 2030.
- In terms of segment, parenteral iron therapy was the largest revenue generating therapy in 2022.
- Oral Iron Therapy is the most lucrative therapy segment registering the fastest growth during the forecast period.
Iron deficiency anemia therapy market data book summary
| Market revenue in 2022 | USD 19.2 million |
| Market revenue in 2030 | USD 40.4 million |
| Growth rate | 9.8% (CAGR from 2022 to 2030) |
| Largest segment | Parenteral iron therapy |
| Fastest growing segment | Oral Iron Therapy |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion, Other Therapies |
| Key market players worldwide | Akebia Therapeutics Inc, Bayer AG, Sanofi SA, Johnson & Johnson, CSL Ltd, AbbVie Inc, Teoxane Laboratories Geneva, Zydus Lifesciences, GSK PLC, Novartis AG ADR, AdvaCare Pharma, Apotex Inc., Apollo Global Management Inc Class A, COSMOS Pharmaceutical Corp |
Other key industry trends
- In terms of revenue, Argentina accounted for 0.4% of the global iron deficiency anemia therapy market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil iron deficiency anemia therapy market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 40.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Iron Deficiency Anemia Therapy Market Scope
Iron Deficiency Anemia Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AdvaCare Pharma | View profile | 51-100 | Cheyenne, Wyoming, United States, North America | https://www.advacarepharma.com/en |
| Akebia Therapeutics Inc | View profile | 167 | 245 First Street, Cambridge, MA, United States, 02142 | https://www.akebia.com |
| COSMOS Pharmaceutical Corp | View profile | 24188 | 4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, Japan, 812-0013 | http://www.cosmospc.co.jp |
| Apotex Inc. | View profile | 10001+ | Toronto, Ontario, Canada, North America | http://www.apotex.com |
| Zydus Lifesciences | View profile | 10001+ | Ahmedabad, Gujarat, India, Asia | https://zyduslife.com/ |
| Teoxane Laboratories Geneva | View profile | 251-500 | Geneva, Geneve, Switzerland, Europe | https://www.teoxane.com |
| Apollo Global Management Inc Class A | View profile | 4945 | 9 West 57th Street, 42nd Floor, New York, NY, United States, 10019 | https://www.apollo.com |
| CSL Ltd | View profile | 32000 | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 | https://www.csl.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Argentina iron deficiency anemia therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to iron deficiency anemia therapy market will help companies and investors design strategic landscapes.
Parenteral iron therapy was the largest segment with a revenue share of 58.33% in 2022. Horizon Databook has segmented the Argentina iron deficiency anemia therapy market based on oral iron therapy, parenteral iron therapy, red blood cell transfusion, other therapies covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Argentina iron deficiency anemia therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Argentina iron deficiency anemia therapy market databook
-
Our clientele includes a mix of iron deficiency anemia therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina iron deficiency anemia therapy market, including forecasts for subscribers. This country databook contains high-level insights into Argentina iron deficiency anemia therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Argentina iron deficiency anemia therapy market report size, by therapy, 2018-2030 (US$M)
Argentina Iron Deficiency Anemia Therapy Market Share, 2022 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
